Two projects from within the BIST Community – CliniSuite from CNAG-CRG and ELECTRA from ICIQ – will take part in the 2021 edition of The Collider programme, an initiative run by the Mobile World Capital Foundation.
The Collider programme connects groups of entrepreneurs with scientific teams to bring to market science-based initiatives that have passed the validation phase in the lab but are not yet advanced enough for commercialisation.
This year, two projects from BIST centres were among the 15 winning initiatives selected from 268 applications.
This CNAG-CRG project will evaluate the impact of a potential spin-off involving genomic data analysis technologies and their integration with clinical data to improve the diagnosis of diseases, a key aspect in the new era of personalised medicine.
Over the last few years, Alberto Bucci, ICIQ Postdoctoral Researcher, together with Group Leader and ICREA Prof. Julio Lloret-Fillol have been developing the ELECTRA project, an innovative production method to increase the efficiency and performance of electrodes for water electrolysers while lowering production costs. The project is now on the first of four stages of The Collider programme. Each of the stages of the programme provides new understanding of the development of business ideas, getting them one step closer to their Minimum Viable Product (MVP).
Bridging the gap between science and business is the overall objective of The Collider programme. It does this by providing a response to the challenges of industry and society by means of deep-tech innovation. The Collider has awarded € 2,000 to each of the 15 selected projects, thanks to a collaboration with the Department of Business and Knowledge of the Generalitat de Catalunya. This edition of The Collider programme received 268 proposals of which 39 were qualified projects in the health, industry, agri-food, energy and utilities, and mobility sectors; 54% of the projects came from Catalan institutions, with 38% from the Spanish research ecosystem and 8% from abroad.